CRKN stock plunges to 52-week low of $4.26 amid market turbulence

Published 19/02/2025, 19:12
CRKN stock plunges to 52-week low of $4.26 amid market turbulence

Crown Electrokinetics Corp. (CRKN) stock has hit a distressing 52-week low, dropping to $4.26, as the company faces severe market headwinds. According to InvestingPro analysis, the company’s market capitalization has contracted to just $1.82 million, though technical indicators suggest the stock is currently in oversold territory. This latest price level reflects a staggering 1-year change, with the stock value plummeting by -99.81%. Investors are grappling with the stark reality of this significant downturn, as the company’s shares struggle to regain lost ground in a challenging economic environment. Despite the current challenges, analysts project significant revenue growth of 811% this year, and the stock appears undervalued based on comprehensive Fair Value analysis available through InvestingPro’s detailed research reports.

In other recent news, Crown Electrokinetics Corp. announced a 1-for-150 reverse stock split of its common stock, effective January 30, 2025. This strategic move aims to consolidate shares to maintain the company’s Nasdaq listing, which Crown’s CEO, Doug Croxall, considers vital for the company’s growth and credibility. Despite the reverse split, Crown maintains a healthy cash balance exceeding $25 million and is experiencing growing revenues. The company also recently expanded its team, welcoming Andy Mayer and his expertise in disaster rehabilitation and pipeline industries. In another development, Crown Electrokinetics received a notification from Nasdaq about non-compliance with the exchange’s minimum bid price requirement. The company has been under a Mandatory Panel Monitor since July 25, 2024, and due to multiple reverse stock splits, it is ineligible for a compliance period under Nasdaq rules. Crown plans to request a hearing before the Nasdaq Hearings Panel to delay any delisting actions, although there is no certainty of continued listing. The company’s stock will continue trading on the Nasdaq under the ticker "CRKN" during this process.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.